Literature DB >> 8107256

Photoinactivation and kinetics of membrane fusion mediated by the human immunodeficiency virus type 1 envelope glycoprotein.

D S Dimitrov1, R Blumenthal.   

Abstract

The fusion kinetics of cells expressing the human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein with CD4 target cells was continuously monitored by image-enhanced Nomarski differential interference contrast optics. The analysis of the videotape recordings showed that (i) cells made contact relatively rapidly (within minutes), in many cases by using microspikes to "touch" and adhere to adjoining cells; (ii) the adhered cells fused after a relatively long waiting period, which varied from 15 min to hours; (iii) the morphological changes after membrane fusion, which led to disappearance of the interface separating the two cells, were rapid (less than 1 min); and (iv) the process of syncytium formation involved subsequent fusion with other cells and not simultaneous fusion of many cells. To measure the kinetics of early stages of cell fusion, we used the recently developed very stable membrane-soluble dye, PKH26, which redistributes between labeled and unlabeled membranes after fusion but does not exchange spontaneously between membranes for prolonged periods. We found that photoactivation of this dye by illumination with green light inhibits fusion of cell membranes as indicated by the lack of dye transfer from the labeled HIV-1 envelope-expressing cells to unlabeled CD4 cells. The inhibitory effect was localized in space and time, which allowed us to develop a new assay for measuring the kinetics of membrane fusion by illuminating the cell mixture at different times after coculture. This assay has also been used to monitor the fusion kinetics of HIV-1 and recombinant vaccinia virus. The photoactivation of nonexchangeable membrane-soluble fluorescent dyes may be useful for development of new assays for measuring the kinetics of membrane fusion and could also be important in designing new antiviral approaches.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8107256      PMCID: PMC236658     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Long-term tracking of lymphocytes in vivo: the migration of PKH-labeled lymphocytes.

Authors:  G F Teare; P K Horan; S E Slezak; C Smith; J B Hay
Journal:  Cell Immunol       Date:  1991-04-15       Impact factor: 4.868

2.  Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein.

Authors:  J D Lifson; M B Feinberg; G R Reyes; L Rabin; B Banapour; S Chakrabarti; B Moss; F Wong-Staal; K S Steimer; E G Engleman
Journal:  Nature       Date:  1986 Oct 23-29       Impact factor: 49.962

3.  Fusion of intra- and extracellular forms of vaccinia virus with the cell membrane.

Authors:  R W Doms; R Blumenthal; B Moss
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

4.  Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses.

Authors:  P L Earl; S Koenig; B Moss
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

Review 5.  Photodynamic inactivation of animal viruses: a review.

Authors:  C Wallis; J L Melnick
Journal:  Photochem Photobiol       Date:  1966-03       Impact factor: 3.421

6.  Neutralization of HIV-1 and inhibition of HIV-1-induced syncytia by 1,8-naphthalimide photoactive compound.

Authors:  T C Chanh; D E Lewis; J S Allan; F Sogandares-Bernal; M M Judy; R E Utecht; J L Matthews
Journal:  AIDS Res Hum Retroviruses       Date:  1993-09       Impact factor: 2.205

7.  Chemically induced CD4 mutants of a human T cell line. Evidence for dissociation between binding of HIV I envelope and susceptibility to HIV I infection and syncytia formation.

Authors:  K Hillman; O Shapira-Nahor; M F Gruber; J Hooley; J Manischewitz; R Seeman; L Vujcic; S J Geyer; H Golding
Journal:  J Immunol       Date:  1990-03-15       Impact factor: 5.422

8.  AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen.

Authors:  J D Lifson; G R Reyes; M S McGrath; B S Stein; E G Engleman
Journal:  Science       Date:  1986-05-30       Impact factor: 47.728

9.  T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV.

Authors:  D Klatzmann; E Champagne; S Chamaret; J Gruest; D Guetard; T Hercend; J C Gluckman; L Montagnier
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

10.  Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope.

Authors:  S Matsushita; M Robert-Guroff; J Rusche; A Koito; T Hattori; H Hoshino; K Javaherian; K Takatsuki; S Putney
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

View more
  14 in total

1.  Resistance to a drug blocking human immunodeficiency virus type 1 entry (RPR103611) is conferred by mutations in gp41.

Authors:  B Labrosse; O Pleskoff; N Sol; C Jones; Y Hénin; M Alizon
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Role of cholesterol in human immunodeficiency virus type 1 envelope protein-mediated fusion with host cells.

Authors:  Mathias Viard; Isabella Parolini; Massimo Sargiacomo; Katia Fecchi; Carlo Ramoni; Sherimay Ablan; Francis W Ruscetti; Ji Ming Wang; Robert Blumenthal
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  HIV-1 envelope protein gp41: an NMR study of dodecyl phosphocholine embedded gp41 reveals a dynamic prefusion intermediate conformation.

Authors:  Nils-Alexander Lakomek; Joshua D Kaufman; Stephen J Stahl; Paul T Wingfield
Journal:  Structure       Date:  2014-08-14       Impact factor: 5.006

4.  Inactivation of retroviruses with preservation of structural integrity by targeting the hydrophobic domain of the viral envelope.

Authors:  Yossef Raviv; Mathias Viard; Julian W Bess; Elena Chertova; Robert Blumenthal
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41.

Authors:  I Muñoz-Barroso; S Durell; K Sakaguchi; E Appella; R Blumenthal
Journal:  J Cell Biol       Date:  1998-01-26       Impact factor: 10.539

6.  Physiological levels of virion-associated human immunodeficiency virus type 1 envelope induce coreceptor-dependent calcium flux.

Authors:  Marta Melar; David E Ott; Thomas J Hope
Journal:  J Virol       Date:  2006-11-22       Impact factor: 5.103

7.  Internal dynamics of the homotrimeric HIV-1 viral coat protein gp41 on multiple time scales.

Authors:  Nils-Alexander Lakomek; Joshua D Kaufman; Stephen J Stahl; John M Louis; Alexander Grishaev; Paul T Wingfield; Ad Bax
Journal:  Angew Chem Int Ed Engl       Date:  2013-02-28       Impact factor: 15.336

8.  Synergistic inhibition of human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion and infection by an antibody to CD4 domain 2 in combination with anti-gp120 antibodies.

Authors:  L Burkly; N Mulrey; R Blumenthal; D S Dimitrov
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

9.  Amphotericin B derivative blocks human immunodeficiency virus type 1 entry after CD4 binding: effect on virus-cell fusion but not on cell-cell fusion.

Authors:  O Pleskoff; M Seman; M Alizon
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

10.  Cell fusion in tumor progression: the isolation of cell fusion products by physical methods.

Authors:  Filippo Pedrazzoli; Iraklis Chrysantzas; Luca Dezzani; Vittorio Rosti; Massimo Vincitorio; Giammaria Sitar
Journal:  Cancer Cell Int       Date:  2011-09-20       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.